Glucose tolerance status in pregnancy: A window to the future risk of diabetes and cardiovascular disease in young women

Current Diabetes Reviews

Volumn 5, Issue 4, 2009, Pages 239-244

  Retnakaran, Ravi ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardiovascular disease; Gestational diabetes; Glucose intolerance; Pregnancy; Screening; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; N(G),N(G) DIMETHYLARGININE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; ENDOTHELIAL DYSFUNCTION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POPULATION RISK; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; UPREGULATION;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 70450195278     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909789804378     Document Type: Review

References (70)

1. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749-1756
2. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115(3): 485-491
3. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30(Suppl 2): S141-6. (Pubitemid 47036416)
4. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25(10): 1862-1868
5. Hanna FW, Peters JR. Screening for gestational diabetes: past, present and future. Diabet Med 2002; 19(5): 351-358 (Pubitemid 34534208)
6. Agarwal MM, Dhatt GS, Punnose J, Koster G. Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 2005; 22: 1731-1736 (Pubitemid 43046476)
7. Canadian Diabetes Association clinical practice guidelines expert committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32(Suppl 1): S168-80.
8. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2000; 23: S77-S9.
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28(12): 1039-1057
10. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144(7): 768-773
11. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, et al. The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 2008; 93(5): 1689-1695 (Pubitemid 351656506)
12. Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care 2007; 30(Suppl 2): S105-11.
13. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 2007; 30(Suppl 2): S251-60.
14. Caballero AE. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 2005; 36(3): 241-249
15. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008; 31: 2026-2031
16. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Isolated hyperglycemia at 1-hour on oral glucose tolerance test in pregnancy resembles gestational diabetes in predicting postpartum metabolic dysfunction. Diabetes Care 2008; 31(7): 1275-1281
17. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal. Clin Endocrinol 2009; 71(2): 208-214
18. Retnakaran R, Shah B. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009; 26(5): 474-477
19. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-1467 (Pubitemid 12194400)
20. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672
21. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998; 21: B19-26.
22. Buchanan TA. Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86(3): 989-993
23. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 2008; 16: 1901-1907
24. Retnakaran R, Hanley AJ, Raif N, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48(5): 993-1001. (Pubitemid 40767994)
25. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity. Clin Endocrinol 2009; 70(4): 615-622
26. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19. (Pubitemid 36237741)
27. Vambergue A, Dognin C, Boulogne A, Réjou MC, Biausque S, Fontaine P. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabet Med 2008; 25(1): 58-64.
28. Carr DB, Newton KM, Utzschneider KM, et al. Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care 2008; 31: 1037-1039
29. Corrado F, D'Anna R, Cannata ML, et al. Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance. Am J Obstet Gynecol 2007; 196(4): 339.e1-5 (Pubitemid 46497909)
30. Retnakaran R, Zinman B, Connelly PW, Sermer M, Hanley AJ. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test. Diabetes Care 2006; 29: 57-62. (Pubitemid 44033431)
31. Di Cianni G, Seghieri G, Lencioni C, et al. Normal glucose tolerance and gestational diabetes mellitus: what is in between? Diabetes Care 2007; 30(7): 1783-1788
32. Bentley-Lewis R, Levkoff S, Stuebe A, Seely EW. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008; 4(10): 552-558
33. Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007; 30(Suppl 2): S246-50.
34. Bo S, Valpreda S, Menato G, et al. Should we consider gestational diabetes a vascular risk factor? Atherosclerosis 2007; 194(2): e72-9.
35. Meyers-Seifer, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes Care 1996; 19: 1351-1356
36. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002; 87(7): 3227-3235 (Pubitemid 34816370)
37. Lauenborg J, Mathiesen H, Hansen T, et al. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005; 90(7): 4004-4010 (Pubitemid 41058164)
38. Kousta E, Efstathiadou Z, Lawrence NJ, et al. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia 2006; 49(1): 36-40. (Pubitemid 43151611)
39. Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006; 29(9): 2078-2083 (Pubitemid 44871190)
40. Winzer C, Wagner O, Festa A, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004; 27(7): 1721-1727 (Pubitemid 38857450)
41. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005; 90(7): 3983-3988 (Pubitemid 41058161)
42. Di Benedetto A, Russo GT, Corrado F, et al. Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 2005; 28(1): 34-38 (Pubitemid 43162807)
43. Farhan S, Winzer C, Tura A, et al. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes. Eur J Clin Invest 2006; 36(5): 345-352
44. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007; 23(2): 135-140 (Pubitemid 46306434)
45. Sriharan M, Reichelt AJ, Opperman ML, et al. Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes. Diabetes Care 2002; 25(8): 1331-1335 (Pubitemid 41071141)
46. Mittermayer F, Mayer BX, Meyer A, et al. Circulating concentrations of asymmetrical dimethyl-L-arginine is increased in women with previous gestational diabetes. Diabetologia 2002; 45(10): 1372-1378 (Pubitemid 35244889)
47. Anastasiou E, Lekakis J, Alevizaki M, et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998; 21(12): 2111-2115 (Pubitemid 28549159)
48. Hu J, Norman M, Wallensteen M, Gennser G. Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 1998; 105(12): 1279-1287 (Pubitemid 29002829)
49. Hannemann MM, Liddell WG, Shore AC, Clark PM, Tooke JE. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 2002; 39(4): 311-319 (Pubitemid 34983862)
50. Freire CM, Nunes Mdo C, Barbosa MM, et al. Gestational diabetes: a condition of early diastolic abnormalities in young women. J Am Soc Echocardiogr 2006; 19(10): 1251-1256 (Pubitemid 44416177)
51. Gasic S, Winzer C, Bayerle-Eder M, Roden A, Pacini G, Kautzky- Willer A. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus. Eur J Clin Invest 2007; 37(1): 42-47 (Pubitemid 44934771)
52. Tarim E, Yigit F, Kilicdag E, et al. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2006; 27(2): 177-182 (Pubitemid 43733734)
53. Banerjee M, Cruickshank JK. Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk. Nat Clin Pract Cardiovasc Med 2006; 3(11): 596-603. (Pubitemid 44614921)
54. Volpe L, Di Cianni G, Lencioni C, Cuccuru I, Benzi L, Del Prato S. Gestational diabetes, inflammation and late vascular disease. J Endocrinol Invest 2007; 30(10): 873-879 (Pubitemid 351166312)
55. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes. Diabetes Care 2008; 31: 1668-1669
56. Stern MP. Diabetes and cardiovascular disease. The "common soil hypothesis". Diabetes 1995; 44(4): 369-374
57. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115(18): 2390-2397 (Pubitemid 46717961)
58. Shimbo D, Grahame-Clarke C, Miyake Y, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007; 192(1): 197-203. (Pubitemid 46602298)
59. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002; 25(3): 560-564 (Pubitemid 41103353)
60. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995; 173(1): 146-156
61. Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y. Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 2002; 25(9): 1619-1624 (Pubitemid 41071121)
62. Ostlund I, Hanson U, Bjorklund A, et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 2003; 26(7): 2107-2111 (Pubitemid 41184260)
63. Gruendhammer M, Brezinka C, Lechleitner M. The number of abnormal plasma glucose values in the oral glucose tolerance test and the feto-maternal outcome of pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 108(2): 131-136 (Pubitemid 36629338)
64. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184(2): 77-83. (Pubitemid 32141647)
65. Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993; 81(3): 344-348 (Pubitemid 23085287)
66. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999; 16(6): 269-275
67. Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007; 50: 298-306.
68. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358(19): 1991-2002.
69. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum pre-diabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J Clin Endocrinol Metab 2009; 94(3): 840-845
70. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009, in press.